NP / PA
Notzke, Bailey
Notzke, Bailey was paid $244K by Medicaid between Jun 2023 and Dec 2024, across 27 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoNOTZKE, BAILEY
URBANA, IL 61801
URBANA, IL 61801
33aNPI1588384473assigned 08/31/2022
33bProvider typeWomen's Health Nurse Practitioner
28Total paid$244K
24GClaims5,887
24DCodes billed27
24AFirst – last monthJun 2023 – Dec 2024
Compared with peers
Next to other Women's Health Nurse Practitioner providers in Illinois
Rank by total paid#10 of 82
Median peer was paid$50K
This provider vs. median4.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 918 | $34K | |
| 2024incomplete | 4,969 | $210K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 862 | 689 | $72K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 356 | 300 | $29K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 9.1% | 575 | 479 | $22K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 9.1% | 575 | 478 | $22K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 8.9% | 412 | 349 | $22K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 5.8% | 500 | 407 | $14K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.9% | 137 | 97 | $12K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 4.7% | 140 | 112 | $11K |
| 86780 | 2.6% | 413 | 349 | $6K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 2.3% | 127 | 119 | $5K |
| 86803 | 1.7% | 264 | 216 | $4K | |
| 0500F | 1.7% | 37 | 37 | $4K |
15 more codes
| 96127 | 1.4% | 246 | $4K | |
| 87340 | 1.3% | 255 | $3K | |
| 0502F | <1% | 18 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 327 | $2K |
| 99459 | <1% | 126 | $2K | |
| 81025 | <1% | 286 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 33 | $2K |
| 87511 | <1% | 30 | $1K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 15 | $854.47 |
| 86762 | <1% | 49 | $443.03 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 13 | $372.58 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 51 | $295.80 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 14 | $213.46 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 13 | $183.32 |
| 82950 | <1% | 13 | $57.73 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.